Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report.


Journal

European journal of cancer (Oxford, England : 1990)
ISSN: 1879-0852
Titre abrégé: Eur J Cancer
Pays: England
ID NLM: 9005373

Informations de publication

Date de publication:
05 2021
Historique:
received: 19 12 2020
revised: 08 02 2021
accepted: 15 02 2021
pubmed: 21 3 2021
medline: 26 10 2021
entrez: 20 3 2021
Statut: ppublish

Résumé

This study aimed to report the uptake of hysterectomy and/or bilateral salpingo-oophorectomy (BSO) to prevent gynaecological cancers (risk-reducing surgery [RRS]) in carriers of pathogenic MMR (path_MMR) variants. The Prospective Lynch Syndrome Database (PLSD) was used to investigate RRS by a cross-sectional study in 2292 female path_MMR carriers aged 30-69 years. Overall, 144, 79, and 517 carriers underwent risk-reducing hysterectomy, BSO, or both combined, respectively. Two-thirds of procedures before 50 years of age were combined hysterectomy and BSO, and 81% of all procedures included BSO. Risk-reducing hysterectomy was performed before age 50 years in 28%, 25%, 15%, and 9%, and BSO in 26%, 25%, 14% and 13% of path_MLH1, path_MSH2, path_MSH6, and path_PMS2 carriers, respectively. Before 50 years of age, 107 of 188 (57%) BSO and 126 of 204 (62%) hysterectomies were performed in women without any prior cancer, and only 5% (20/392) were performed simultaneously with colorectal cancer (CRC) surgery. Uptake of RRS before 50 years of age was low, and RRS was rarely undertaken in association with surgical treatment of CRC. Uptake of RRS aligned poorly with gene- and age-associated risk estimates for endometrial or ovarian cancer that were published recently from PLSD and did not correspond well with current clinical guidelines. The reasons should be clarified. Decision-making on opting for or against RRS and its timing should be better aligned with predicted risk and mortality for endometrial and ovarian cancer in Lynch syndrome to improve outcomes.

Identifiants

pubmed: 33743481
pii: S0959-8049(21)00105-2
doi: 10.1016/j.ejca.2021.02.022
pmc: PMC8916840
mid: NIHMS1781077
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article Multicenter Study Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

124-133

Subventions

Organisme : Medical Research Council
ID : G0100496
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : U01 CA167551
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA167551
Pays : United States
Organisme : Department of Health
ID : IS-BRC-1215-20007
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

Fam Cancer. 2020 Apr;19(2):177-182
pubmed: 31997047
N Engl J Med. 2020 Nov 19;383(21):2053-2064
pubmed: 33207095
Genet Med. 2020 Jan;22(1):15-25
pubmed: 31337882
Dis Colon Rectum. 2017 Feb;60(2):137-143
pubmed: 28059909
J Pathol. 2001 Nov;195(4):451-6
pubmed: 11745677
Genet Med. 2021 Apr;23(4):705-712
pubmed: 33257847
Gut. 2017 Mar;66(3):464-472
pubmed: 26657901
Gut. 2018 Jul;67(7):1306-1316
pubmed: 28754778
BJOG. 2021 Mar;128(4):728-736
pubmed: 32725920
Genet Med. 2019 Oct;21(10):2390-2400
pubmed: 30918358
N Engl J Med. 2006 Jan 19;354(3):261-9
pubmed: 16421367
Adv Ther. 2018 Apr;35(4):577-589
pubmed: 29516408
J Clin Med. 2020 Jul 18;9(7):
pubmed: 32708519
Gut. 2017 Sep;66(9):1657-1664
pubmed: 27261338
Nat Genet. 2014 Feb;46(2):107-115
pubmed: 24362816
Dis Colon Rectum. 2017 Aug;60(8):792-799
pubmed: 28682964
Fam Cancer. 2018 Jan;17(1):53-61
pubmed: 28551770
Br J Surg. 2021 May 27;108(5):484-498
pubmed: 34043773
Hered Cancer Clin Pract. 2020 Mar 14;18:6
pubmed: 32190163
Dis Colon Rectum. 2020 Oct;63(10):1393-1402
pubmed: 32969882

Auteurs

Toni T Seppälä (TT)

Department of Gastrointestinal Surgery, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland; Department of Surgical Oncology, Johns Hopkins Hospital, Baltimore, MD, USA; The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), The Polyposis Registry, St Mark's Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, UK; European Hereditary Tumour Group (EHTG), C/o Lindsays, Caledonian Exchange, 19A Canning Street, Edinburgh, EH3 8HE, United Kingdom. Electronic address: toni.seppala@helsinki.fi.

Mev Dominguez-Valentin (M)

Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo, Norway; The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), The Polyposis Registry, St Mark's Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, UK; European Hereditary Tumour Group (EHTG), C/o Lindsays, Caledonian Exchange, 19A Canning Street, Edinburgh, EH3 8HE, United Kingdom.

Emma J Crosbie (EJ)

Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester and St Mary's Hospital, Manchester, UK; Directorate of Gynaecology, Manchester University, NHS Foundation Trust, Manchester, M13 9WL, UK.

Christoph Engel (C)

Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany; The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), The Polyposis Registry, St Mark's Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, UK.

Stefan Aretz (S)

Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Germany.

Finlay Macrae (F)

Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Melbourne, Australia; Department of Medicine, Melbourne University, Melbourne, Australia; The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), The Polyposis Registry, St Mark's Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, UK.

Ingrid Winship (I)

Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Melbourne, Australia; Department of Medicine, Melbourne University, Melbourne, Australia.

Gabriel Capella (G)

Hereditary Cancer Program, Institut Catal. D'Oncologia-IDIBELL Institut D'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), The Polyposis Registry, St Mark's Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, UK; European Hereditary Tumour Group (EHTG), C/o Lindsays, Caledonian Exchange, 19A Canning Street, Edinburgh, EH3 8HE, United Kingdom.

Huw Thomas (H)

St Mark's Hospital, Department of Surgery and Cancer, Imperial College London, London, UK.

Eivind Hovig (E)

Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo, Norway; Department of Informatics, University of Oslo, Oslo, Norway.

Maartje Nielsen (M)

Department of Clinical Genetics, Leids Universitair Medisch Centrum, Leiden, Netherlands.

Rolf H Sijmons (RH)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), The Polyposis Registry, St Mark's Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, UK; European Hereditary Tumour Group (EHTG), C/o Lindsays, Caledonian Exchange, 19A Canning Street, Edinburgh, EH3 8HE, United Kingdom.

Lucio Bertario (L)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy; Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.

Bernardo Bonanni (B)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Maria G Tibiletti (MG)

Ospedale di Circolo ASST Settelaghi, Centro di Ricerca Tumori Eredo-familiari, Università Dell'Insubria, Varese, Italy.

Giulia M Cavestro (GM)

Gastroenterology and Gastrointestinal Endoscopy Unit, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy.

Miriam Mints (M)

Department of Women's and Children's Health, Division of Obstetrics and Gyneacology, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden.

Nathan Gluck (N)

Tel-Aviv Sourasky Medical Center, Research Center for Digestive Disorders and Liver Diseases; Department of Gastroenterology, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Lior Katz (L)

High Risk and GI Cancer Prevention Clinic, Gatro-Oncology Unit, The Department of Gastroenterology, Sheba Medical Center, Israel.

Karl Heinimann (K)

Medical Genetics, Institute for Medical Genetics and Pathology, University Hospital Basel, Switzerland.

Carlos A Vaccaro (CA)

Hereditary Cancer Program (PROCANHE) Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Instituto de Medicina Traslacional e Ingenieria Biomedica (IMTIB), Argentina.

Kate Green (K)

Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.

Fiona Lalloo (F)

Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.

James Hill (J)

Department of Surgery, Manchester University Hospitals NHS Foundation Trust and University of Manchester, Manchester, UK.

Wolff Schmiegel (W)

Department of Medicine, Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany.

Deepak Vangala (D)

Department of Medicine, Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany.

Claudia Perne (C)

Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Germany.

Hans-Georg Strauß (HG)

Department of Gynaecology, University Clinics, Martin-Luther University, Halle-Wittenberg, Germany.

Johanna Tecklenburg (J)

Institute of Human Genetics, Hannover Medical School, Hannover, Germany.

Elke Holinski-Feder (E)

Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany; MGZ- Medical Genetics Center, Munich, Germany; The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), The Polyposis Registry, St Mark's Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, UK; European Hereditary Tumour Group (EHTG), C/o Lindsays, Caledonian Exchange, 19A Canning Street, Edinburgh, EH3 8HE, United Kingdom.

Verena Steinke-Lange (V)

Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany; MGZ- Medical Genetics Center, Munich, Germany.

Jukka-Pekka Mecklin (JP)

Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland & Department of Surgery, Central Finland Health Care District, Jyväskylä, Finland; The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), The Polyposis Registry, St Mark's Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, UK; European Hereditary Tumour Group (EHTG), C/o Lindsays, Caledonian Exchange, 19A Canning Street, Edinburgh, EH3 8HE, United Kingdom.

John-Paul Plazzer (JP)

The Royal Melbourne Hospital, Melbourne, Australia; The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), The Polyposis Registry, St Mark's Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, UK.

Marta Pineda (M)

Hereditary Cancer Program, Institut Català D'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

Matilde Navarro (M)

Hereditary Cancer Program, Institut Català D'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

Joan B Vida (JB)

Hereditary Cancer Program, Institut Català D'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

Revital Kariv (R)

Department of Gastroenterology, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Guy Rosner (G)

Department of Gastroenterology, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Tamara A Piñero (TA)

Instituto de Medicina Traslacional e Ingenieria Biomedica (IMTIB), Argentina.

Walter Pavicic (W)

Instituto de Medicina Traslacional e Ingenieria Biomedica (IMTIB), Argentina.

Pablo Kalfayan (P)

Instituto de Medicina Traslacional e Ingenieria Biomedica (IMTIB), Argentina.

Sanne W Ten Broeke (SW)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Mark A Jenkins (MA)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.

Lone Sunde (L)

Department of Clinical Genetics, Aalborg University Hospital, Aarhus, Denmark; Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Inge Bernstein (I)

Department of Surgical Gastroenterology, Aalborg University Hospital, Aalborg, Denmark; Faculty of Clinical Medicine, Aalborg University, Aalborg, Denmark.

John Burn (J)

Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK; The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), The Polyposis Registry, St Mark's Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, UK; European Hereditary Tumour Group (EHTG), C/o Lindsays, Caledonian Exchange, 19A Canning Street, Edinburgh, EH3 8HE, United Kingdom.

Marc Greenblatt (M)

University of Vermont, Larner College of Medicine, Burlington, VT 05405, USA.

Wouter H de Vos Tot Nederveen Cappel (WH)

Department of Gastroenterology and Hepatology, Isala Clinics, Zwolle, the Netherlands.

Adriana Della Valle (A)

Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Hospital Fuerzas Armadas, Montevideo, Uruguay.

Francisco Lopez-Koestner (F)

Lab. Oncología y Genética Molecular, Unidad de Coloproctología Clínica Las Condes, Santiago, Chile.

Karin Alvarez (K)

Lab. Oncología y Genética Molecular, Unidad de Coloproctología Clínica Las Condes, Santiago, Chile.

Reinhard Büttner (R)

Institute of Pathology, University of Cologne, Cologne, Germany.

Heike Görgens (H)

Department of Surgery, Technische Universität Dresden, Dresden, Germany.

Monika Morak (M)

Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany; MGZ- Medical Genetics Center, Munich, Germany.

Stefanie Holzapfel (S)

Institute of Human Genetics, University of Bonn, Bonn, Germany.

Robert Hüneburg (R)

Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.

Magnus von Knebel Doeberitz (M)

Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Markus Loeffler (M)

Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.

Silke Redler (S)

Heinrich-Heine-University, Medical Faculty, Institute of Human Genetics, Düsseldorf, Germany.

Jürgen Weitz (J)

Department of Surgery, Technische Universität Dresden, Dresden, Germany.

Kirsi Pylvänäinen (K)

Department of Education and Science, Central Finland Health Care District, Jyväskylä, Finland.

Laura Renkonen-Sinisalo (L)

Department of Gastrointestinal Surgery, Helsinki University Central Hospital, Applied Tumour Genomics Research Program, University of Helsinki, Helsinki, Finland.

Anna Lepistö (A)

Department of Gastrointestinal Surgery, Helsinki University Central Hospital, Applied Tumour Genomics Research Program, University of Helsinki, Helsinki, Finland.

John L Hopper (JL)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.

Aung K Win (AK)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Melbourne, VIC, 3010, Australia; Genetic Medicine, Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.

Noralane M Lindor (NM)

Department of Health Science Research, Mayo Clinic Arizona.

Steven Gallinger (S)

Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto.

Loïc Le Marchand (L)

University of Hawaii Cancer Center, Honolulu, HI 96813, USA.

Polly A Newcomb (PA)

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109-1024, USA.

Jane C Figueiredo (JC)

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109-1024, USA.

Stephen N Thibodeau (SN)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.

Christina Therkildsen (C)

The Danish HNPCC Register, Clinical Research Centre, Copenhagen University Hospital, Hvidovre, Denmark.

Karin A W Wadt (KAW)

Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Denmark.

Marian J E Mourits (MJE)

Department of Gynaecologic Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Zohreh Ketabi (Z)

Dept. of Obstetrics and Gynaecology, Copenhagen University Hospital, Rigshospitalet, Denmark.

Oliver G Denton (OG)

Institute of Medical Genetics, Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK.

Einar A Rødland (EA)

Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo, Norway.

Hans Vasen (H)

Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, the Netherlands.

Florencia Neffa (F)

Lab. Oncología y Genética Molecular, Unidad de Coloproctología Clínica Las Condes, Santiago, Chile.

Patricia Esperon (P)

Lab. Oncología y Genética Molecular, Unidad de Coloproctología Clínica Las Condes, Santiago, Chile.

Douglas Tjandra (D)

Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Melbourne, Australia.

Gabriela Möslein (G)

Department of Surgery, Ev. Krankenhaus Bethesda Hospital, Duisburg, Germany; The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), The Polyposis Registry, St Mark's Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, UK; European Hereditary Tumour Group (EHTG), C/o Lindsays, Caledonian Exchange, 19A Canning Street, Edinburgh, EH3 8HE, United Kingdom.

Erik Rokkones (E)

Department of Gynaecological Oncology, Division of Cancer Medicine, The Norwegian Radium Hospital, Oslo, Norway.

Julian R Sampson (JR)

Institute of Medical Genetics, Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK; The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), The Polyposis Registry, St Mark's Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, UK; European Hereditary Tumour Group (EHTG), C/o Lindsays, Caledonian Exchange, 19A Canning Street, Edinburgh, EH3 8HE, United Kingdom.

D G Evans (DG)

Division of Evolution and Genomic Medicine, University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Pål Møller (P)

Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo, Norway; The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), The Polyposis Registry, St Mark's Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, UK; European Hereditary Tumour Group (EHTG), C/o Lindsays, Caledonian Exchange, 19A Canning Street, Edinburgh, EH3 8HE, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH